siRNA therapies (Phyzat Biopharmaceuticals)

N/A

Report date: 2025/06/11 10:57:26
NME

Base Information

Drug NamesiRNA therapies (Phyzat Biopharmaceuticals)
Drug Alias NamePZ-8603-111PZ-4501-134PZ-8645-245PZ-8603-114
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugal
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhyzat Biopharmaceuticals Lda
China Registration ClassN/A

Develop Information

Active CompaniesPhyzat Biopharmaceuticals Lda
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A